Nomura Holdings’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,730
| Closed | -$296K | – | 1241 |
|
|
2025
Q1 | $296K | Sell |
64,730
-62
| -0.1% | -$283 | ﹤0.01% | 912 |
|
|
2024
Q4 | $365K | Buy |
64,792
+19
| +0% | +$107 | ﹤0.01% | 1256 |
|
|
2024
Q3 | $314K | Sell |
64,773
-10
| -0% | -$48 | ﹤0.01% | 737 |
|
|
2024
Q2 | $316K | Buy |
64,783
+46,037
| +246% | +$225K | ﹤0.01% | 815 |
|
|
2024
Q1 | $249K | Sell |
18,746
-330
| -2% | -$4.38K | ﹤0.01% | 788 |
|
|
2023
Q4 | $266K | Buy |
19,076
+900
| +5% | +$12.5K | ﹤0.01% | 908 |
|
|
2023
Q3 | $241K | Sell |
18,176
-900
| -5% | -$11.9K | ﹤0.01% | 668 |
|
|
2023
Q2 | $358K | Sell |
19,076
-1,250
| -6% | -$23.4K | ﹤0.01% | 569 |
|
|
2023
Q1 | $293K | Sell |
20,326
-12,521
| -38% | -$181K | ﹤0.01% | 684 |
|
|
2022
Q4 | $634K | Buy |
+32,847
| New | +$634K | ﹤0.01% | 555 |
|